000 01320 a2200325 4500
005 20250513162403.0
264 0 _c19990209
008 199902s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM199902043400507
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHavlir, D V
245 0 0 _aTuberculosis in patients with human immunodeficiency virus infection.
_h[electronic resource]
260 _bThe New England journal of medicine
_cFeb 1999
300 _a367-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAIDS-Related Opportunistic Infections
_xdiagnosis
650 0 4 _aAnti-HIV Agents
_xtherapeutic use
650 0 4 _aAntitubercular Agents
_xtherapeutic use
650 0 4 _aDisease Susceptibility
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHumans
650 0 4 _aPolymorphism, Restriction Fragment Length
650 0 4 _aRifampin
_xtherapeutic use
650 0 4 _aTuberculosis
_xdiagnosis
650 0 4 _aTuberculosis, Multidrug-Resistant
_xdrug therapy
700 1 _aBarnes, P F
773 0 _tThe New England journal of medicine
_gvol. 340
_gno. 5
_gp. 367-73
856 4 0 _uhttps://doi.org/10.1056/NEJM199902043400507
_zAvailable from publisher's website
999 _c9891155
_d9891155